PREVIOUS QUESTION:

 

NEXT QUESTION:

 

Does SVR help your liver?

ANSWER

Sustained virologic response (SVR) means that 12 weeks or more after you stop treatment for hepatitis C, tests can’t find the virus in your blood.

SVR stops damage to your liver from hep C. It can slow or stop liver disease if you have it. Your liver starts to do its job better, and important substances called enzymes usually return to normal levels. It might even improve your results of treatment for liver cancer.

Still, damage may continue or get worse if you have fatty liver disease or drink a lot of alcohol. Some liver scarring, called fibrosis, might remain, but it often decreases.

SOURCES:

American Association for the Study of Liver Diseases: "Initial Treatment of Adults with HCV Infection," "HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C."

CDC: "Hepatitis C Questions and Answers for Health Professionals," "Hepatitis C Questions and Answers for the Public."

Infohep.org: "Hepatitis C treatment factsheet: Harvoni (sofosbuvir + ledipasvir)."

Hepatitis C Online: "Goals and Benefits with HCV Treatment," "Ledipasvir-Sofosbuvir (Harvoni)."

Merck Manual: "Overview of Chronic Hepatitis."

The Hepatitis Trust: "Hepatitis C Virus (HCV) Diagnostics Fact Sheet," "Genotypes of hepatitis C," "Harvoni."

Treatment Action Group: "Hepatitis C Virus (HCV) Diagnostics Fact Sheet," "Harvoni Fact Sheet."

University of Maryland School of Pharmacy: "Transferability of Economic

Evaluation Studies: Is There a Generally Accepted Alternative Price Benchmark to the WAC Price?"

U.S. Department of Veterans Affairs: "FAQs about Sustained Virologic Response to

Treatment for Hepatitis C," "Viral Hepatitis and Liver Disease," "Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations."

Federal Bureau of Prisons: "Evaluation and management of chronic hepatitis c virus (HCV) infection."

Reviewed by Melinda Ratini on May 29, 2020

SOURCES:

American Association for the Study of Liver Diseases: "Initial Treatment of Adults with HCV Infection," "HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C."

CDC: "Hepatitis C Questions and Answers for Health Professionals," "Hepatitis C Questions and Answers for the Public."

Infohep.org: "Hepatitis C treatment factsheet: Harvoni (sofosbuvir + ledipasvir)."

Hepatitis C Online: "Goals and Benefits with HCV Treatment," "Ledipasvir-Sofosbuvir (Harvoni)."

Merck Manual: "Overview of Chronic Hepatitis."

The Hepatitis Trust: "Hepatitis C Virus (HCV) Diagnostics Fact Sheet," "Genotypes of hepatitis C," "Harvoni."

Treatment Action Group: "Hepatitis C Virus (HCV) Diagnostics Fact Sheet," "Harvoni Fact Sheet."

University of Maryland School of Pharmacy: "Transferability of Economic

Evaluation Studies: Is There a Generally Accepted Alternative Price Benchmark to the WAC Price?"

U.S. Department of Veterans Affairs: "FAQs about Sustained Virologic Response to

Treatment for Hepatitis C," "Viral Hepatitis and Liver Disease," "Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations."

Federal Bureau of Prisons: "Evaluation and management of chronic hepatitis c virus (HCV) infection."

Reviewed by Melinda Ratini on May 29, 2020

NEXT QUESTION:

What are hepatitis C genotypes?

WAS THIS ANSWER HELPFUL

"ALEXA, ASK WEBMD"

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.